300 related articles for article (PubMed ID: 11256478)
1. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
Rao LG; Liu LJ; Rawlins MR; McBroom RJ; Murray TM; Reddy GS; Uskokovic MR; Rao DS; Sutherland MK
Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478
[TBL] [Abstract][Full Text] [Related]
2. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM
Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029
[TBL] [Abstract][Full Text] [Related]
3. 17 beta-oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner.
Rao LG; Wylie JN; Kung Sutherland MS; Murray TM
J Endocrinol; 1996 Jan; 148(1):181-7. PubMed ID: 8568466
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: association of receptor levels with alkaline phosphatase activity.
Sutherland MK; Hui DU; Rao LG; Wylie JN; Murray TM
Bone; 1996 Apr; 18(4):361-9. PubMed ID: 8726395
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
[TBL] [Abstract][Full Text] [Related]
6. Positive interaction between 17 beta-Estradiol and parathyroid hormone in normal human osteoblasts cultured long term in the presence of dexamethasone.
Rao LG; Kung Sutherland MS; Muzaffar SA; Wylie JN; McBroom RJ; Murray TM
Osteoporos Int; 1996; 6(2):111-9. PubMed ID: 8704348
[TBL] [Abstract][Full Text] [Related]
7. Effect of 17 beta-estradiol on the human osteosarcoma cell line MG-63.
Lajeunesse D
Bone Miner; 1994 Jan; 24(1):1-16. PubMed ID: 8186730
[TBL] [Abstract][Full Text] [Related]
8. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
[TBL] [Abstract][Full Text] [Related]
9. 17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells.
Ishibe M; Nojima T; Ishibashi T; Koda T; Kaneda K; Rosier RN; Puzas JE
Calcif Tissue Int; 1995 Dec; 57(6):430-5. PubMed ID: 8581875
[TBL] [Abstract][Full Text] [Related]
10. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
11. Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.
Rao LG; Murray TM; Wylie JN; McBroom RJ; Sutherland MK
J Endocrinol Invest; 2005 Nov; 28(10):919-27. PubMed ID: 16419495
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner.
Rao LG; Wylie JN; Sutherland MS; Murray TM
Endocrinology; 1994 Feb; 134(2):614-20. PubMed ID: 8299560
[TBL] [Abstract][Full Text] [Related]
13. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
Curtis KM; Aenlle KK; Roos BA; Howard GA
Mol Endocrinol; 2014 May; 28(5):644-58. PubMed ID: 24597546
[TBL] [Abstract][Full Text] [Related]
14. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
[TBL] [Abstract][Full Text] [Related]
15. Influence of skeletal site of origin and donor age on 1,25(OH)2D3-induced response of various osteoblastic markers in human osteoblastic cells.
Martínez ME; Medina S; Sánchez M; Del Campo MT; Esbrit P; Rodrigo A; Martínez P; Sánchez-Cabezudo MJ; Moreno I; Garcés MV; Munuera L
Bone; 1999 Mar; 24(3):203-9. PubMed ID: 10071912
[TBL] [Abstract][Full Text] [Related]
16. Sex steroids and bone metabolism: comparison of in vitro effects of 17beta-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation.
Fohr B; Schulz A; Battmann A
Exp Clin Endocrinol Diabetes; 2000; 108(6):414-23. PubMed ID: 11026755
[TBL] [Abstract][Full Text] [Related]
17. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro.
Jurutka PW; Terpening CM; Haussler MR
Biochemistry; 1993 Aug; 32(32):8184-92. PubMed ID: 8394128
[TBL] [Abstract][Full Text] [Related]
18. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
19. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
